Novo CEO pressed by Senate to cut prices of obesity, diabetic issues medication CEO Lars Fruergaard Jørgensen informed lawmakers the corporate would look at new talks with insurers regarding the record charges of Wegovy and copyright should they pledge to keep the medicines on their formularies. Pay attention to the https://kethek.com/